Experimental studies at the University of Texas are showing good results for a vaccine that could possibly slow down Alzheimer’s disease. The experiments and research are published in the journal Alzheimer’s Research & Therapy.
The research included animal testing on monkeys and rabbits in hope to bring to human trials soon. If all goes well with the testing and it is proven safe for humans this could help reduce the risk of people developing dementia and Alzheimer’s disease. Researchers believe that they are making major progress with the safety and effectiveness of this vaccine.
In earlier experimental attempts researchers failed and studies showed harmful side effects on the subjects such as inflammation. The vaccine now works with the body to help produce antibodies that will help stop the buildup of tau and amyloid proteins that become deadly on the brain. They saw several different areas of the brain that had reduced the buildup of the harmful plaque that gets all over the brain.
An estimated 5.7 million Americans suffer from Alzheimer’s disease today. By 2050 the number of Americans is estimated to double to around 10 million. If scientists and researchers are able to successfully create this vaccine it could help a lot of people reduce their risk of developing this awful disease in the future.
If you or a loved one is interested in learning more about Long Term Care Insurance be sure to checkout: LTC TREE for more information.
Reviews of each company’s financial stability ratings, claims experience, and size.
A side-by-side comparison of each company’s policy features. We cover the similarities and the differences.
Price comparisons customized to suit your specific needs from top carriers such as Nationwide, Thrivent, New York Life, National Guardian Life, Mutual of Omaha, and more.